{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:17:14Z","timestamp":1794367034034,"version":"4.9.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Toll-like receptor 8 (TLR8) gain-of-function (GOF) somatic variants were recently identified as causing severe neutropenia, lymphoproliferation, and immune dysregulation. We report the expanded clinical and laboratory phenotype and management of 10 patients, including the original cohort of 6 male patients. We identify the first female patient with TLR8 GOF who presented during infancy with pure red cell aplasia due to a germ line TLR8 variant, and 2 new disease-causing somatic variants in male patients. Eight patients had somatic mosaicism with peripheral blood variant allele fractions of 7% to 26%, and age of disease onset of 9 months to 28 years. All patients had neutropenia, most with severe neutropenia refractory to medical therapy. Anemia and thrombocytopenia were common. Bone marrow characteristically demonstrated severe myeloid hypoplasia and activated T-cell infiltrates and\/or aggregates. An increased number of large granular lymphocytes (LGLs) was identified in 5 patients. Seven patients underwent allogeneic hematopoietic cell transplant (HCT). High rates of post-HCT cytopenia of unclear etiology and graft-versus-host disease were observed. Five patients are surviving at 1 to 3 years after HCT with full donor myeloid and T-cell chimerism, and resolution of disease phenotype. The 2 patients who presented during childhood and did not undergo HCT ultimately died from disease. In conclusion, TLR8 GOF is an X-linked dominant disorder that should be considered in male and female patients with cytopenia, particularly severe neutropenia, lymphoproliferation with immune dysregulation, increased LGLs, and new to this cohort, red cell aplasia. Disease is refractory to medical management, and curative, allogeneic HCT should be considered early after diagnosis. This trial was registered at www.clinicaltrials.gov as #NCT04339777.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016338","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T18:04:36Z","timestamp":1765389876000},"page":"1967-1976","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-806X","authenticated-orcid":false,"given":"Danielle E.","family":"Arnold","sequence":"first","affiliation":[{"name":"1Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Kaviany","sequence":"additional","affiliation":[{"name":"2Division of Hematology\/Oncology, Department of Pediatrics, Columbia University Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Aluri","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6404-930X","authenticated-orcid":false,"given":"Sarah S.","family":"Mehta","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-5087","authenticated-orcid":false,"given":"Joshua M.","family":"Tobin","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Schuettpelz","sequence":"additional","affiliation":[{"name":"5Division of Hematology\/Oncology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermina","family":"Saucier","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Schmitz","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-3366","authenticated-orcid":false,"given":"Luis","family":"Murgu\u00eda-Favela","sequence":"additional","affiliation":[{"name":"6Section of Hematology\/Immunology, Department of Pediatrics, Alberta Children\u2019s Hospital, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-4969","authenticated-orcid":false,"given":"Nicola A.M.","family":"Wright","sequence":"additional","affiliation":[{"name":"6Section of Hematology\/Immunology, Department of Pediatrics, Alberta Children\u2019s Hospital, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9800-774X","authenticated-orcid":false,"given":"Suk See","family":"De Ravin","sequence":"additional","affiliation":[{"name":"7Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Instititutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-6902","authenticated-orcid":false,"given":"V. Koneti","family":"Rao","sequence":"additional","affiliation":[{"name":"7Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Instititutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-5464","authenticated-orcid":false,"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[{"name":"7Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Instititutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J.","family":"Bleesing","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"9Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Loughran Jr","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Virginia School of Medicine and University of Virginia Cancer Center, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Feith","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Virginia School of Medicine and University of Virginia Cancer Center, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-5162","authenticated-orcid":false,"given":"Jonathan","family":"Powell","sequence":"additional","affiliation":[{"name":"11Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Nemours\/Alfred I. duPont Hospital for Children, Wilmington, DE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-3056","authenticated-orcid":false,"given":"Aakrosh","family":"Ratan","sequence":"additional","affiliation":[{"name":"12Department of Genome Sciences, University of Virginia School of Medicine, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-6444","authenticated-orcid":false,"given":"Julia T.","family":"Warren","sequence":"additional","affiliation":[{"name":"13Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"14Department of Pediatrics, Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-8147","authenticated-orcid":false,"given":"Sung-Yun","family":"Pai","sequence":"additional","affiliation":[{"name":"1Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-0876","authenticated-orcid":false,"given":"Jeffrey J.","family":"Bednarski","sequence":"additional","affiliation":[{"name":"5Division of Hematology\/Oncology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-375X","authenticated-orcid":false,"given":"James A.","family":"Connelly","sequence":"additional","affiliation":[{"name":"15Division of Pediatric Hematology and Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-172X","authenticated-orcid":false,"given":"Megan A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"3Division of Rheumatology\/Immunology, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"6","key":"2026032014071104400_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/cmi.2012.38","article-title":"TLR8: the forgotten relative revindicated","volume":"9","author":"Cervantes","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"2026032014071104400_bib2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3389\/fimmu.2019.01209","article-title":"Human Toll-like receptor 8 (TLR8) is an important sensor of pyogenic bacteria, and is attenuated by cell surface TLR signaling","volume":"10","author":"Moen","year":"2019","journal-title":"Front Immunol"},{"issue":"18","key":"2026032014071104400_bib3","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.2020009620","article-title":"Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function","volume":"137","author":"Aluri","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2026032014071104400_bib4","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2026032014071104400_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-021-01177-2","article-title":"The immune deficiency and dysregulation activity (IDDA2.1 \u2018Kaleidoscope\u2019) score and other clinical measures in inborn errors of immunity","volume":"42","author":"Seidel","year":"2022","journal-title":"J Clin Immunol"},{"issue":"1","key":"2026032014071104400_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multi-center standardization of acute graft-versus-host disease clinical data collection: a report from the MAGIC Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2026032014071104400_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2026032014071104400_bib15","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1038\/s41467-024-50066-w","article-title":"Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemia","volume":"15","author":"Liang","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"2026032014071104400_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.26452","article-title":"TLR8\/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins","volume":"97","author":"Fejtkova","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"2026032014071104400_bib9","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"2026032014071104400_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026032014071104400_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol"},{"issue":"12","key":"2026032014071104400_bib11","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.jmedchem.1c00300","article-title":"Structural evolution and translational potential for agonists and antagonists of endosomal toll-like receptors","volume":"64","author":"Talukdar","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"2026032014071104400_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13293-023-00544-5","article-title":"TLR8 escapes X chromosome inactivation in human monocytes and CD4+ T cells","volume":"14","author":"Youness","year":"2023","journal-title":"Biol Sex Differ"},{"issue":"10","key":"2026032014071104400_bib12","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/cells10102800","article-title":"Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options","volume":"10","author":"Calabretto","year":"2021","journal-title":"Cells"},{"issue":"10","key":"2026032014071104400_bib14","doi-asserted-by":"crossref","first-page":"e202302241","DOI":"10.26508\/lsa.202302241","article-title":"Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice","volume":"6","author":"Maria","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"88","key":"2026032014071104400_bib16","doi-asserted-by":"crossref","first-page":"e20232066","DOI":"10.1084\/jem.20232066","article-title":"Gain-of-function human UNC93B1 variants cause systemic lupus erythematous and chilblain lupus","volume":"221","author":"David","year":"2024","journal-title":"J Exp Med"},{"issue":"6","key":"2026032014071104400_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41590-024-01846-5","article-title":"Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus","volume":"25","author":"Al-Azab","year":"2024","journal-title":"Nat Immunol"},{"issue":"4","key":"2026032014071104400_bib17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"2026032014071104400_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nchembio.2518","article-title":"Small-molecule inhibition of TLR8 through stabilization of its resting state","volume":"14","author":"Zhang","year":"2018","journal-title":"Nat Chem Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1967\/2508503\/blooda_adv-2025-016338-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1967\/2508503\/blooda_adv-2025-016338-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:07:20Z","timestamp":1774030040000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/6\/1967\/557217\/Clinical-characteristics-management-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016338","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,24]]},"published":{"date-parts":[[2026,3,13]]}}}